Showing results (111-120 of 148) with videos related to

Sort By:
Pageof 15
Journal of Immunology Research|September 16, 2017
Erratum to "Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients"Sang Jin Lee, Won Park, Sung Hwan Park, et al.
Plos One|August 15, 2019
Correction: Prevalence and predictors for sustained remission in rheumatoid arthritisYoon-Kyoung Sung, Kazuki Yoshida, Femke H M Prince, et al.
Archives of Rheumatology|March 16, 2019
Effects of Tocilizumab Therapy on Serum Interleukin-33 and Interleukin-6 Levels in Patients With Rheumatoid ArthritisIn Ah Choi, Sang Jin Lee, Won Park, et al.
Journal of Immunology Research|April 30, 2015
Low baseline interleukin-17A levels are associated with better treatment response at 12 weeks to tocilizumab therapy in rheumatoid arthritis patientsSang Jin Lee, Won Park, Sung Hwan Park, et al.
Journal of Clinical Medicine|December 10, 2020
Autoantibodies against Protein Phosphatase Magnesium-Dependent 1A as a Biomarker for Predicting Radiographic Progression in Ankylosing Spondylitis Treated with Anti-Tumor Necrosis Factor AgentsJung-Sun Lee, Eun-Ju Lee, Jae-Hyun Lee, et al.
Plos One|April 20, 2019
Prevalence and predictors for sustained remission in rheumatoid arthritisYoon-Kyoung Sung, Kazuki Yoshida, Femke H M Prince, et al.
Clinical and Experimental Rheumatology|July 13, 2018
Efficacy and safety of mycophenolate mofetil and tacrolimus combination therapy in patients with lupus nephritis: a nationwide multicentre studyDong-Jin Park, Ji-Hyoun Kang, Kyung-Eun Lee, et al.
Annals of the Rheumatic Diseases|February 1, 2025
Genetic burden of lupus increases the risk of transition from normal to preclinical autoimmune conditions via antinuclear antibody developmentSehwan Chun, So-Young Bang, Ayeong Kwon, et al.
Modern Rheumatology|December 11, 2013
A comparison of incidence and risk factors for serious adverse events in rheumatoid arthritis patients with etanercept or adalimumab in Korea and JapanSoo-Kyung Cho, Ryoko Sakai, Toshihiro Nanki, et al.
Annals of the Rheumatic Diseases|February 1, 2025
Mitochondrial transplantation as a novel therapeutic approach in idiopathic inflammatory myopathyJeong Yeon Kim, Young Cheol Kang, Min Jung Kim, et al.
Pageof 15